An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions - PubMed (original) (raw)

An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions

W Böcker et al. Virchows Arch A Pathol Anat Histopathol. 1992.

Abstract

The distribution of simple epithelial (K8/18/19) and basal (myoepithelial) (K5/14) keratins, alpha-smooth-muscle actin, vimentin, collagen IV and laminin in normal mammary glands and in benign proliferative lesions was studied using monoclonal antibodies (mAbs). These antibodies (Abs) identified myoepithelial cells and luminal cells specifically. In lesions with adenosis and papillomas, the two-layered formation resembled that of normal glands with a purely myoepithelial-epithelial differentiation. In scleradenotic lesions, the main cell was of myoepithelial immunophenotype with intermixed trabecular-tubular proliferations of simple-type epithelium. The sclerosis seems to be the result of an irregular basal lamina synthesis by the myoepithelial cells. In contrast to these lesions, epitheliosis represents a purely intraluminal cell proliferation of clearly simple epithelial immunophenotype and of cells with a basal keratin phenotype, lacking myoepithelial differentiation antigen actin. The basal keratin type epithelium may represent post-stem or intermediate cells developing into luminal epithelium. Epitheliosis appears to be a purely epithelial hyperplasia with striking similarity to the regeneration of normal breast epithelium. The different proliferative patterns may give an explanation for differences in potential cancer risks of patients with these lesions.

PubMed Disclaimer

Cited by

Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer.
Pellacani D, Tan S, Lefort S, Eaves CJ. Pellacani D, et al. EMBO J. 2019 Jul 15;38(14):e100330. doi: 10.15252/embj.2018100330. Epub 2019 Jan 11. EMBO J. 2019. PMID: 31304632 Free PMC article. Review.
Spontaneous Mammary Adenocarcinoma in a Twelve-week-old Female Sprague-Dawley Rat.
Kuzutani K, Shibanushi T, Kangawa Y, Kihara T. Kuzutani K, et al. J Toxicol Pathol. 2012 Sep;25(3):221-4. doi: 10.1293/tox.25.221. Epub 2012 Oct 1. J Toxicol Pathol. 2012. PMID: 22988341 Free PMC article.
[Immunohistochemistry in breast pathology: differential diagnosis of epithelial breast lesions].
Böcker W, Hungermann D, Weigel S, Tio J, Decker T. Böcker W, et al. Pathologe. 2009 Feb;30(1):13-9. doi: 10.1007/s00292-008-1103-2. Pathologe. 2009. PMID: 19184023 German.
Understanding and treating triple-negative breast cancer.
Anders C, Carey LA. Anders C, et al. Oncology (Williston Park). 2008 Oct;22(11):1233-9; discussion 1239-40, 1243. Oncology (Williston Park). 2008. PMID: 18980022 Free PMC article. Review.
The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW. Tse GM, et al. J Clin Pathol. 2007 Mar;60(3):315-20. doi: 10.1136/jcp.2006.036830. Epub 2006 May 12. J Clin Pathol. 2007. PMID: 16698948 Free PMC article.

References

1. Am J Surg Pathol. 1990 Oct;14(10):939-47 - PubMed
1. Curr Top Pathol. 1970;53:161-220 - PubMed
1. Lab Invest. 1983 Sep;49(3):353-61 - PubMed
1. Am J Pathol. 1984 Jan;114(1):9-17 - PubMed
1. J Cell Biol. 1980 Mar;84(3):633-54 - PubMed

MeSH terms

Substances

LinkOut - more resources

Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions - PubMed (original) (raw)